Cole Petrochko
Med Page Today
January 4, 2011
The maker of a nebulized asthma treatment recalled several drug lots due to health hazards posed by erroneous labeling on unit vials.
The Ritedose Corporation improperly labeled vials of its 0.083% Albuterol Sulfate Inhalation Solution, 3 mL in 25-, 30-, and 60-unit dose vials with a concentration of 0.5 mg/3 mL rather than 2.5 mg/3 mL.
Patients who are given the drug based on the mislabeled concentration may get five times the intended dose of the solution and may suffer adverse effects ranging from temporary to fatal, a statement from Ritedose said.
The Emergency Election Sale is now live! Get 30% to 60% off our most popular products today!